Skip to main content
Log in

Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension

  • IM - ORIGINAL
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

This study analyses the frequency and the potential role of two polymorphisms, the +134del/insA, located in the gene encoding for Endothelin-1 (EDN1), and the His323His in the gene encoding for Endothelin receptor type A (EDNRA) in a cohort of 98 consecutive patients with pulmonary arterial hypertension from two different Cardiology Units (Mid-South of Italy), and in 100 healthy Caucasian subjects randomly recruited from the same area. Cardiac anatomy and function were analysed by non invasive diagnostic imaging techniques (Echocardiography standard m-mode, 2D, colour-Doppler) and by invasive studies (cardiac catheterization). Molecular screening of the region of interest was performed by automated sequencing. At univariate analysis, patients with the His323His TT genotype show a lower cardiac index (2 ± 0.6 vs. 2.3 ± 0.6; p = 0.05) and a higher indexed pulmonary vascular resistance (18.8 ± 9.6 vs. 14.2 ± 6.9; p = 0.01) at cardiac catheterization. A logistic multivariate model shows idiopathic disease (p = 0.01; OR = 3.8; CI = 1.3–11) and indexed pulmonary vascular resistances (p = 0.01; OR = 1.1; CI = 1–1.2) as independent predictors of TT genotype. Our findings may suggest a potential link between specific genotypes in the EDNRA gene and susceptibility for PAH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wu SC, Caravita S, Lisi E et al (2009) Pulmonary arterial hypertension. Intern Emerg Med 4:459–470

    Article  PubMed  Google Scholar 

  2. Galiè N, Hoeper MM, Humbert M et al (2009) Task force for diagnosis and treatment of pulmonary hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34(6):1219–1263

    Article  PubMed  Google Scholar 

  3. Giaid A (1998) Nitric oxide and endothelin-1 in pulmonary hypertension. Chest 114:208S–212S

    Article  PubMed  CAS  Google Scholar 

  4. Penna C, Rastaldo R, Mancardi D et al (2006) Effect of endothelins on the cardiovascular system. J Cardiovasc Med (Hagerstown) 7:645–652

    Article  Google Scholar 

  5. Popowski K, Sperker B, Kroemer HK et al (2003) Functional significance of a hereditary adenine insertion variant in the 59-UTR of the endothelin-1 gene. Pharmacogenetics 13:445–451

    Article  PubMed  CAS  Google Scholar 

  6. Herrmann SM, Schmidt-Petersen K, Pfeifer J et al (2001) A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy. Eur Heart J 22:1948–1953

    Article  PubMed  CAS  Google Scholar 

  7. Tiret L, Poirier O, Hallet V et al (1999) The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33(5):1169–1174

    Article  PubMed  CAS  Google Scholar 

  8. Ghofrani HA, Barst RJ, Benza RL et al (2009) Future perspectives for the treatment of pulmonary arterial hypertension. J Am Coll Cardiol 54(1 Suppl):S108–S117

    Article  PubMed  Google Scholar 

  9. Jin JJ, Nakura J, Wu Z et al (2003) Association of endothelin-1 gene variant with hypertension. Hypertension 41(1):163–167

    Article  PubMed  CAS  Google Scholar 

  10. Dong Y, Wang X, Zhu H et al (2004) Endothelin-1 gene and progression of blood pressure and left ventricular mass: longitudinal findings in youth. Hypertension 44:884–890

    Article  PubMed  CAS  Google Scholar 

  11. D’Alto M, Vizza CD, Romeo E et al (2007) Long term effects of Bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect. Heart 93:621–625

    Article  PubMed  Google Scholar 

  12. Galiè N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30:2493–2537

    Article  PubMed  Google Scholar 

  13. Budhiraja R, Tuder RM, Hassoun PM (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109:159–165

    Article  PubMed  Google Scholar 

  14. Yamanaka R, Otsuka F, Nakamura K et al (2010) Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension. Hypertens Res 33(5):435–445

    Article  PubMed  CAS  Google Scholar 

  15. Schiffrin EL, Deng LY, Sventek P et al (1997) Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension. J Hypertens 15:57–63

    Article  PubMed  CAS  Google Scholar 

  16. Giaid A, Yanagisawa M, Langleben D et al (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328(24):1732–1739

    Article  PubMed  CAS  Google Scholar 

  17. Day R, Larivière R, Schiffrin EL (1995) In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 8:294–300

    Article  PubMed  CAS  Google Scholar 

  18. Hirata Y, Yoshimi H, Takaichi S et al (1988) Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett 239(1):13–17

    Article  PubMed  CAS  Google Scholar 

  19. Rubens C, Ewert R, Halank M et al (2001) Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 120(5):1562–1569

    Article  PubMed  CAS  Google Scholar 

  20. Hosoda K, Nakao K, Tamura N et al (1992) Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem 267:18797–18804

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We express our gratitude to all the nurses of the Division of Paediatric and Adult Cardiology, Monaldi Hospital, for the technical support and cooperation in the outpatient clinic, particularly Mrs Assunta Carandente, Mrs Antonella Nannolo, Mrs Assunta Di Vaio, and Mrs Debora De Santis. This work was supported in part by Grants to Prof. Calabrò R.from the Actelion Pharmaceuticals Italia SRL. (2008).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paolo Calabrò.

Additional information

P. Calabrò and G. Limongelli equally contributed to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calabrò, P., Limongelli, G., Maddaloni, V. et al. Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension. Intern Emerg Med 7, 425–430 (2012). https://doi.org/10.1007/s11739-011-0643-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-011-0643-2

Keywords

Navigation